Literature DB >> 18456100

Global burden of blood-pressure-related disease, 2001.

Carlene M M Lawes1, Stephen Vander Hoorn, Anthony Rodgers.   

Abstract

BACKGROUND: Few studies have assessed the extent and distribution of the blood-pressure burden worldwide. The aim of this study was to quantify the global burden of disease related to high blood pressure.
METHODS: Worldwide burden of disease attributable to high blood pressure (> or =115 mm Hg systolic) was estimated for groups according to age (> or =30 years), sex, and World Bank region in the year 2001. Population impact fractions were calculated with data for mean systolic blood pressure, burden of deaths and disability-adjusted life years (DALYs), and relative risk corrected for regression dilution bias.
FINDINGS: Worldwide, 7.6 million premature deaths (about 13.5% of the global total) and 92 million DALYs (6.0% of the global total) were attributed to high blood pressure. About 54% of stroke and 47% of ischaemic heart disease worldwide were attributable to high blood pressure. About half this burden was in people with hypertension; the remainder was in those with lesser degrees of high blood pressure. Overall, about 80% of the attributable burden occurred in low-income and middle-income economies, and over half occurred in people aged 45-69 years.
INTERPRETATION: Most of the disease burden caused by high blood pressure is borne by low-income and middle-income countries, by people in middle age, and by people with prehypertension. Prevention and treatment strategies restricted to individuals with hypertension will miss much blood-pressure-related disease.

Entities:  

Mesh:

Year:  2008        PMID: 18456100     DOI: 10.1016/S0140-6736(08)60655-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  743 in total

1.  Blood pressure-lowering efficacy of an olmesartan medoxomil/hydrochlorothiazide-based treatment algorithm in elderly patients (age ≥65 years) stratified by age, sex and race: subgroup analysis of a 12-week, open-label, single-arm, dose-titration study.

Authors:  Joel Neutel; Dean J Kereiakes; Kathy A Stoakes; Jen-Fue Maa; Ali Shojaee; William F Waverczak
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

2.  Associations between psychosocial work environment and hypertension among non-Western immigrant and Danish cleaners.

Authors:  Kasper Olesen; Isabella G Carneiro; Marie B Jørgensen; Reiner Rugulies; Charlotte D N Rasmussen; Karen Søgaard; Andreas Holtermann; Mari-Ann Flyvholm
Journal:  Int Arch Occup Environ Health       Date:  2011-12-17       Impact factor: 3.015

3.  Methylmercury and elemental mercury differentially associate with blood pressure among dental professionals.

Authors:  Jaclyn M Goodrich; Yi Wang; Brenda Gillespie; Robert Werner; Alfred Franzblau; Niladri Basu
Journal:  Int J Hyg Environ Health       Date:  2012-04-09       Impact factor: 5.840

4.  Incidence and prognosis of resistant hypertension in hypertensive patients.

Authors:  Stacie L Daugherty; J David Powers; David J Magid; Heather M Tavel; Frederick A Masoudi; Karen L Margolis; Patrick J O'Connor; Joe V Selby; P Michael Ho
Journal:  Circulation       Date:  2012-02-29       Impact factor: 29.690

5.  Targeting Pim Kinases and DAPK3 to Control Hypertension.

Authors:  David A Carlson; Miriam R Singer; Cindy Sutherland; Clara Redondo; Leila T Alexander; Philip F Hughes; Stefan Knapp; Susan B Gurley; Matthew A Sparks; Justin A MacDonald; Timothy A J Haystead
Journal:  Cell Chem Biol       Date:  2018-07-19       Impact factor: 8.116

6.  High-intensity interval training lowers blood pressure and improves apelin and NOx plasma levels in older treated hypertensive individuals.

Authors:  Mohammad Reza Izadi; Alireza Ghardashi Afousi; Maryam Asvadi Fard; Mohammad Ali Babaee Bigi
Journal:  J Physiol Biochem       Date:  2017-12-06       Impact factor: 4.158

7.  Beyond the clinic: importance of community involvement in sodium-reduction efforts.

Authors:  Cheryl A M Anderson
Journal:  J Public Health Manag Pract       Date:  2014 Jan-Feb

Review 8.  Incretins and selective renal sodium-glucose co-transporter 2 inhibitors in hypertension and coronary heart disease.

Authors:  Ramiro A Sanchez; Hugo Sanabria; Cecilia de Los Santos; Agustin J Ramirez
Journal:  World J Diabetes       Date:  2015-09-10

9.  The impact of aerobic exercise on blood pressure variability.

Authors:  N Pagonas; F Dimeo; F Bauer; F Seibert; F Kiziler; W Zidek; T H Westhoff
Journal:  J Hum Hypertens       Date:  2013-11-28       Impact factor: 3.012

10.  Common variant rs11191548 near the CYP17A1 gene is associated with hypertension and the serum 25(OH) D levels in Han Chinese.

Authors:  Ning Zhang; Jian Jia; Qiuju Ding; Huimei Chen; Xiaoman Ye; Haixia Ding; Yiyang Zhan
Journal:  J Hum Genet       Date:  2018-03-19       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.